Anteotech
Anteotech Ltd specializes in the development and commercialization of advanced medical diagnostics and energy storage solutions, leveraging its proprietary nanotechnology platform. It operates in healthcare and energy sectors, aiming for a significant market position through innovative solutions such as its proprietary AnteoBind™ technology, which enhances the sensitivity and performance of diagnostic assays.
Short position
Anteotech (ASX:ADO) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,321 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.56% in February 2026. ADO is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Anteotech (ADO) company profile
Profile, insiders and operations
Company
AI-generated research profile of Anteotech
ADO intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links